Market Introduction
The North America virus-like particles market analysis is based on three major countries: the US, Canada, and Mexico. Among North America provinces, US holds the largest size of the VLP's market due to reported viral infections, for example, variant influenza viruses. According to the Centers for Disease Control and Prevention (CDC), the majority of the conditions of variant viruses have mainly occurred in children aged 18 years or younger with the onset of illness, according to the report by the Centers for Disease Control and Prevention (CDC). Additionally, consistent R&D activities to manufacture live attenuated vaccines by the biopharmaceutical company positively impact the market growth.
In the North American provinces, the US was the most affected country due to COVID-19. This was due to the US showing an uneven response during the onset of COVID-19 coupled with insufficiencies in testing resources. To overcome the transmission rate of COVID-19, the development of the vaccine was on edge for all biopharmaceutical companies with a high focus on recombinant COVID-19 vaccines. As recombinant vaccines include recombinant spike protein vaccines, recombinant receptor-binding domain vaccines, and virus-like particles, it has gained high importance. Also, the development of more effective and targeted forms of VLP by modification of the surface of the particles in a fashion that they can be introduced into specific cells or tissues is likely to grow in the forthcoming years. Recent advances in the production of VLP's involve the different types of expression systems for the development as well as application of vaccines in the prevention of infectious diseases. In the North American region, countries where COVID-19 vaccines are currently being developed, including the US, Canada, and Cuba. Among these countries, the US has eleven vaccines, while Canada and Cuba possess three vaccines. Additionally, there are six protein subunit vaccines comprising of VLPs, five vector vaccines, and five nucleic acid vaccines. But the manufacturing of virus-like particles still remains challenging in terms of design, purification, and storage. Challenges are majorly associated with the bioprocessing technique that deals with respiratory issues. However, with strong advancement in technology it ultimately develops a series of novel, stable, and efficient VLP based vaccine candidates in the near future.
Market Overview and Dynamics
The virus-like particles market in North America is expected to grow from US$ 1,928.37 million in 2021 to US$ 3,312.49 million by 2028; it is estimated to grow at a CAGR of 8.0% from 2021 to 2028. Various players in the healthcare market and research organizations are actively involved in product innovations and developments. The use of virus-like particles is an emerging approach used in the biopharmaceuticals industry. As virus-like particles lack the viral content, they are easier to handle than the actual viral components. The VLPs can be used for aiding drug delivery, imaging, immunotherapy, and theragnostic. For instance, as per a study published in the NCBI in June 2020, VLP can be used in the form of nanoparticles in applications such as photothermal therapy, PET and CT imaging, MRI contrast agent carriers, optical imaging, inflammatory and autoimmune disease vaccines, cancer immunotherapy, and small molecule drug delivery (in cancer therapy). Thus, such potential applications of VLPs are expected to provide growth opportunities to market players during the forecast period.
Key Market Segments
In terms of product type, the hepatitis segment accounted for the largest share of the North America virus-like particles market in 2021. In terms of source, the yeast segment accounted for the largest share of the North America virus-like particles market in 2021. In term of application, vaccines segment held a larger market share of the virus-like particles market in 2021.
Major Sources and Companies Listed
A few major primary and secondary sources referred to for preparing this report on the virus-like particles market in North America are company websites, annual reports, financial reports, national government documents, and statistical database, among others. Major companies listed in the report are Merck & Co., Inc.; GlaxoSmithKline plc.; Pfizer Inc.; Sanofi; Serum Institute of India Pvt. Ltd.; BHARAT BIOTECH; LG Chem; VBI Vaccines Inc.; and Dynavax Technologies among others.
Reasons to buy report
North America Virus-like Particles Market Segmentation
North America Virus-like Particles Market – By Product type
North America Virus-like Particles Market – By Source
North America Virus-like Particles Market – By Application
North America Virus-like Particles Market – By Country
North America Virus-like Particles Market – Companies Mentioned
| Report Attribute | Details |
|---|---|
| Market size in 2021 | US$ 1,928.37 Million |
| Market Size by 2028 | US$ 3,312.49 Million |
| CAGR (2021 - 2028) | 8.0% |
| Historical Data | 2019-2020 |
| Forecast period | 2022-2028 |
| Segments Covered |
By Product Type
|
|
Regions and Countries Covered
|
|
| North America | US, Canada, Mexico |
| Market leaders and key company profiles |
|
The North America Virus-like Particles Market is valued at US$ 1,928.37 Million in 2021, it is projected to reach US$ 3,312.49 Million by 2028.
As per our report North America Virus-like Particles Market, the market size is valued at US$ 1,928.37 Million in 2021, projecting it to reach US$ 3,312.49 Million by 2028. This translates to a CAGR of approximately 8.0% during the forecast period.
The North America Virus-like Particles Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America Virus-like Particles Market report:
The North America Virus-like Particles Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The North America Virus-like Particles Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the North America Virus-like Particles Market value chain can benefit from the information contained in a comprehensive market report.
Please tell us your area of interest
(Market Segments/ Regions and Countries/ Companies)
E 1803, Panchshil Towers,
Wagholi, Haveli,
Pune - 412207,
Maharashtra, India
US:+1 646 791 7070
sales@businessmarketinsights.com
Get Free Sample For North America Virus-like Particles Market
